Log in

3613 Beijing Tong Ren Tang Chinese Medicine Co., Ltd. HKEX · Hong Kong

Beijing Tong Ren Tang Chinese Medicine Co. (3613) news

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3613, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Beijing Tong Ren Tang Chinese Medicine Co. news

We have not published a story on Beijing Tong Ren Tang Chinese Medicine Co. yet. When there is news, it will appear here.

Questions about Beijing Tong Ren Tang Chinese Medicine Co.

What is the ticker symbol of Beijing Tong Ren Tang Chinese Medicine Co.?

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. trades under the ticker 3613 on HKEX.

Where is Beijing Tong Ren Tang Chinese Medicine Co. listed?

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. is listed on HKEX.

Which country or territory is Beijing Tong Ren Tang Chinese Medicine Co. listed under?

Our directory records Beijing Tong Ren Tang Chinese Medicine Co., Ltd. under Hong Kong.

What does Beijing Tong Ren Tang Chinese Medicine Co. do?

Our directory classifies Beijing Tong Ren Tang Chinese Medicine Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Beijing Tong Ren Tang Chinese Medicine Co.?

The ISIN recorded for Beijing Tong Ren Tang Chinese Medicine Co., Ltd. is HK0000145638.

Does aibio.space cover Beijing Tong Ren Tang Chinese Medicine Co.?

aibio.space lists Beijing Tong Ren Tang Chinese Medicine Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Beijing Tong Ren Tang Chinese Medicine Co.?

Companies in our directory listed in the same country and business area as Beijing Tong Ren Tang Chinese Medicine Co.: China Resources Pharmaceutical Group, Sanai Health Industry Group Company, Dawnrays Pharmaceutical Holdings, Pak Fah Yeow International, SSY Group, Grand Pharmaceutical Group.

Investor discussion: Beijing Tong Ren Tang Chinese Medicine Co.

Members talk about Beijing Tong Ren Tang Chinese Medicine Co. (3613). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Press releases

Headlines of Beijing Tong Ren Tang Chinese Medicine Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    Voluntary Announcement - Receiving the Certificate of Registration of Proprietary Chinese Medicine

  2. HKEXnews

    Continuing Connected Transactions Regarding the E-Commerce Services Cooperation Framework Agreement

  3. HKEXnews

    2026 Interim Results Announcement

  4. HKEXnews

    Continuing Connected Transactions Regarding the Product Sales Framework Agreement

  5. HKEXnews

    Poll Results of Annual General Meeting Held on 10 June 2026

  6. HKEXnews

    Notice of Annual General Meeting

  7. HKEXnews

    Financial Information Announcement of Tong Ren Tang Technologies for the First Quarter of 2026

  8. HKEXnews

    Special Dividend for the Year Ended 31 December 2025 and Closure of Register of Members

  9. HKEXnews

    Final Dividend for the Year Ended 31 December 2025 and Closure of Register of Members

  10. HKEXnews

    Annual Results Announcement For The Year Ended 31 December 2025

  11. HKEXnews

    POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 11 FEBRUARY 2026

  12. HKEXnews

    Continuing Connected Transactions

  13. HKEXnews

    Notice of Extraordinary General Meeting

  14. HKEXnews

    (i) Continuing Connected Transactions regarding the Renewed TRT Group PRC Distribution Framework Agreement; and (ii) Notice of EGM

  15. HKEXnews

    Continuing Connected Transactions Regarding the Renewed TRT Group PRC Distribution Framework Agreement

  16. HKEXnews

    Continuing Connected Transactions Regarding the Renewed Master Lease Framework Agreement

  17. HKEXnews

    CONTINUING CONNECTED TRANSACTIONS REGARDING THE NEW TRADEMARK LICENCE FRAMEWORK AGREEMENT

  18. HKEXnews

    Financial Information Announcement of Tong Ren Tang Technologies For The Third Quarter of 2025

  19. HKEXnews

    Voluntary Announcement - Receiving the Traditional Medicine Registration License

  20. HKEXnews

    Notification Letter to Non-registered Shareholders and Request Form - Notice of Publication of 2025 Interim Report

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:3613 on TradingView.

Listing details

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3613, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Ticker
3613
Listing
HKEX
Country or territory
Hong Kong
Business scope
Pharmaceuticals: Major
ISIN
HK0000145638
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.